All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

PURPOSE: Peripheral T cell lymphomas (PTCLs) have an overall poor prognosis. Indeed, registry data in elderly patients show that the median progression-free survival (mPFS) following first- and second-line therapies are only 6.7 and 3.1 months, respectively. The aim of the study is to show the activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Maria Christina, Banchi, Marta, Pelliccia, Sabrina, Di Napoli, Arianna, Marcheselli, Luigi, Patti, Caterina, Anticoli Borza, Paola, Battistini, Roberta, Di Gregorio, Francesca, Orlandi, Paola, Bocci, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568761/
https://www.ncbi.nlm.nih.gov/pubmed/33070248
http://dx.doi.org/10.1007/s00280-020-04172-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568761/
https://www.ncbi.nlm.nih.gov/pubmed/33070248
http://dx.doi.org/10.1007/s00280-020-04172-3

Ejemplares similares